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Abstract
Background: As human embryonic stem cell (hESC) lines can be derived via multiple means, it is important to determine
particular characteristics of individual lines that may dictate the applications to which they are best suited. The objective of
this work was to determine points of equivalence and differences between conventionally-derived hESC and parthenote-
derived hESC lines (phESC) in the undifferentiated state and during neural differentiation.
Methodology/Principal Findings: hESC and phESC were exposed to the same expansion conditions and subsequent neural
and retinal pigmented epithelium (RPE) differentiation protocols. Growth rates and gross morphology were recorded during
expansion. RTPCR for developmentally relevant genes and global DNA methylation profiling were used to compare gene
expression and epigenetic characteristics. Parthenote lines proliferated more slowly than conventional hESC lines and
yielded lower quantities of less mature differentiated cells in a neural progenitor cell (NPC) differentiation protocol.
However, the cell lines performed similarly in a RPE differentiation protocol. The DNA methylation analysis showed similar
general profiles, but the two cell types differed in methylation of imprinted genes. There were no major differences in gene
expression between the lines before differentiation, but when differentiated into NPCs, the two cell types differed in
expression of extracellular matrix (ECM) genes.
Conclusions/Significance: These data show that hESC and phESC are similar in the undifferentiated state, and both cell
types are capable of differentiation along neural lineages. The differences between the cell types, in proliferation and extent
of differentiation, may be linked, in part, to the observed differences in ECM synthesis and methylation of imprinted genes.
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Introduction
Human pluripotent stem cells (hPSCs) have tremendous
potential for cell replacement, drug screening, predictive toxicol-
ogy and developmental studies. There are multiple methods for
generating hPSCs, including blastocyst derivation [1] derivation
from single blastomeres [2], parthenogenesis [3], and induced
pluripotency [4]. Pluripotent cell lines have also been derived from
chromosomally abnormal spontaneous teratomas [5]. It is
remarkable that these substantial differences in starting material
and derivation methods yield cell lines that have fundamentally
identical capabilities for pluripotency and self-renewal. However,
the source of cell lines may have subtler consequences, perhaps
leading to preferences for specific lineages or different tendencies
toward tumorigenicity. Such phenotypic proclivities may be
reflected in cellular morphology, behavior, or epigenetic state.
To begin to investigate differences among pluripotent cell types,
we chose two cell types that are of great interest for development
of cell replacement therapies, conventionally-derived hESCs, and
hES cell lines derived from parthenote embryos (phESC). While
conventionally-derived hESC lines comply with most of the
proposed standards for use in clinical cell replacement therapies,
there remains considerable concern about rejection of the
transplanted stem cell derivatives, which would require the use
of life-long immunosuppression. A number of approaches have
been proposed to circumvent the need for immunosuppression
after cell transplants. These methods include genetic modifications
of cells; for example, replacing MHC genes, expression of Fas
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making patient-specific pluripotent cells are promising, but they
are currently impractical for clinical applications. Somatic cell
nuclear transfer (SCNT) has not yet been achieved using human
cells, and the most efficient methods for generating induced
pluripotent stem cells (iPSCs) from an individual’s somatic cells
involve genetic engineering, which raises the bar for FDA approval
considerably [4,6].
The most viable short-term option for generation of histocom-
patible hPSCs is to create a cell bank of hESCs that are compatible
with a wide range of HLA types. One means to increase the utility
of such banks is to include parthenogenetic hESC lines, which may
have simpler HLA haplotypes and therefore be histocompatible
with a wider range of individuals. The first intentionally created
phESCs were derived from a blastocyst inner cell mass obtained
from an unfertilized oocyte activated by chemical stimuli [3]; these
cells demonstrated typical characteristics displayed by hESC,
including proliferation, expression of typical markers of pluripo-
tency and differentiation in vitro and in vivo into cells of all germ
layer lineages. Different activation techniques allow creation of
either HLA heterozygous phESC that are totally HLA matched
with oocyte donors, or HLA homozygous phESC which are
histocompatible with significant segments of the human popula-
tion [3,7,8,9].
In order to determine whether parthenogenetic hESC lines and
conventionally-derived hESC lines displayed any phenotypic
differences that might affect their utility for human clinical
applications, we compared hESC and phESC using a battery of
cellular and molecular analyses. Our data revealed differences
between hESC and phESC during propagation and differentia-
tion, as well as molecular differences in imprinting and expression
of ECM genes.
Materials and Methods
Undifferentiated Cell Culture
Eight cell lines were investigated, three conventionally-derived
(H7, H9 and CSC14) and five parthenote-derived (LLC2P,
LLC6P, LLC7P, LLC8P and LLC9P). The CSC14 line was
provided by California Stem Cell Corporation. The five LLC lines
were derived and described by International Stem Cell Corpora-
tion[3]; in that publication, LLC2P was referred to as phESC-1,
LLC6P as phESC-3, LLC7P as phESC-4, LLC8P as phESC-5
and LLC9P as phESC-6.
Two different cell culture systems were used: feeder-free and on
human neonatal skin derived fibroblasts (NSF) described in
Revazova et al. [3]. In the feeder-free culture system, hESC and
phESC cultures were passaged weekly with collagenase IV
(Invitrogen) onto MatriGel
TM-coated flasks (Fisher, CB-40230)
and conditioned growth medium was replaced every day. Growth
medium consisted of KODMEM-F12 with 20% KOSR, 1% non-
essential amino acids, 0.5% GlutaMAX-I (all from Life Sciences
Inc.) and 7 ml/l b-mercaptoethanol (Sigma-Aldrich). This medium
was supplemented with 4 ng/ml bFGF (GF003-AF, Millipore) and
conditioned on irradiated mouse embryonic fibroblasts (MEFs)
overnight, then filtered in a 0.1 mm PES filter (Fisher) before being
supplemented with an additional10 ng/ml bFGF. The number of
colonies were counted at Day 1 after passaging.
In the NSF feeder culture system, undifferentiated phESC and
hESC were maintained on a feeder layer of mitomycin C
mitotically inactivated NSF in KODMEM/F12 (Invitrogen)
supplemented with 15% KOSR (Invitrogen), 0.05 mM non-
essential amino acids (Invitrogen), 2 mM GlutaMAX-I (Invitro-
gen), penicillin/streptomycin (Invitrogen), 55 mM b-mer-
capthoethonol (Invitrogen) and 5 ng/ml recombinant human
FGF-basic (PeproTech). Cultures were manually passaged at 1:4
– 1:6 split ratio every 5–7 days using collagenase IV (Invitrogen).
PCR
Two different PCR arrays from SA Biosciences (Frederick, MD)
were run on samples of four lines (CSC14, H7, LLC6P and
LLC8P): the Stem Cell Array (PAHS-405, SA Biosciences) on
undifferentiated samples and the ECM array (PAHS-013, SA
Biosciences) on NPC. Cells were exposed to collagenase (in the
case of undifferentiated samples) (Invitrogen) or TrpLE (in the case
of NPC) (Invitrogen), pelleted and exposed to 1 ml of Trizol
(15596-018, Invitrogen) per 1610‘6 cells, then homogenized. The
TURBO DNA-free Kit (AM1907, Applied Biosystems, Foster
City, CA) was used and the manufacturer’s protocol was followed.
The RNeasy Mini Kit (74104, Qiagen, Valencia, CA) was used
and RNA was purified according to the manufacturer’s protocol.
The SA Biosciences First Strand Kit (C-03) was used, followed by
the SA Biosciences RNA QC PCR Array (PAHS-999). Three
Stem Cell Array plates were run for each undifferentiated sample
and three ECM plates were run for each NPC sample, for a total
of 12 plates of each type. Data was analyzed with the online
SABiosciences webportal (http://www.sabiosciences.com/pcr/
arrayanalysis.php).
Methylation Microarray
Microarray-based DNA methylation analysis was performed on
two technical replicates for each line assayed on the Illumina
Infinium Human Methylation 27 BeadChip array (Illumina, Inc.).
This array interrogates 27,578 CpG sites representing roughly
14,500 genes. Aliquots containing 1610
6 cells of H7, CSC14,
LLC2P, LLC6P, LLC7P, LLC8P and LLC9P were flash frozen
for DNA purification and subsequent methylation analysis.
Genomic DNA was purified using the DNeasy Kit (Qiagen) and
quantified with Picogreen (Invitrogen). These samples were
compared to the hESC lines HES2, KSR-HSF6, KSR-Miz6
and Mel1; the primary cell lines NuFF’s, Feeder-12age-HDF,
HDF-neonatal, Huevec-BF4, SC01-C-glia, SC11-glia, SC30-C-
fibroblasts, SC31-C-MSC; and tissue samples from colon, female
Caucasian blood, ovary, prostate and breast. Five hundred
nanograms of genomic DNA from technical replicates of each
cell line were bisulfite-converted using the EZ DNA Methylation
Kit (Zymo Research). The bisulfite-converted DNA was processed
and hybridized to the Human Methylation 27 BeadChip
(Illumina, Inc.), according to the manufacturer’s protocol and
scanned on a BeadArray Reader (Illumina, Inc.). The degree of
methylation was expressed as the b-value, where b=methylated/
(methylated+unmethylated). The b-values for each sample were
normalized by range-scaling the data for each probe, using data
from fully methylated (generated by treating genomic DNA with
SssI DNA methyltransferase), fully unmethylated (generated by
whole-genome amplification of genomic DNA), and partially
methylated (generated by mixing equal amounts of fully
methylated and fully unmethylated genomic DNA) control
samples run in triplicate. Because CpG sites assigned to imprinted
genes were not necessarily imprinted, it was necessary to devise a
post hoc method of identifying imprinted loci. Therefore, probes
assigned to imprinted genes were selected and a filter applied to
select only sites that were partially methylated in tissue samples (as
is expected of imprinted loci).
NPC Differentiation
NPC differentiations were carried out on four lines: H7,
CSC14, LLC6P and LLC8P. LLC6P and LLC8P were selected
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they most closely resembled conventionally-derived hESC in
growth rate and colony morphology. Differentiations were carried
out using each of the four lines at the same time with the same
reagents and media. Differentiations were repeated with three
successive passages of cells for a total of three grows. All four cell
lines used for differentiation were brought to subconfluence in the
feeder-free culture system before beginning the differentiation
protocols.
H7 passage 38, 40 and 41 were used. CSC14 passage 39, 40 and
41 were used. LLC6P passage 38, 39 and 40 were used. LLC8P
passage 31, 32 and 33 were used. In a novel differentiation
protocol, subconfluent hESC were dissociated with collagenase IV
and plated in ultra low adherence 6-well plates for sphere
formation at a density of 200,000 cells/cm
2. For the first two days,
cells were fed 50% conditioned medium (described above) and
50% neuron medium (NM). NM consisted of DMEM-F12+
GlutaMAX, 2% B27, 1% ITS (insulin, transferrin, selenium)
(Invitrogen), 1 mM MgCl
2 (M4880, Sigma) and 4 ng/ml bFGF
(Chemicon). From day 3 forward, cells were fed 100% NM. On
days 2–6, medium was further supplemented with 10 mM all-trans
retinoic acid (RA) in DMSO (Sigma-Aldrich). Cells were fed daily
until day 6, after which they were fed three days a week, typically
Monday, Wednesday and Friday. On day 14, cells were plated
onto Matrigel-coated flasks at a density of 200,000 cells/cm
2.O n
day 21, cells were dissociated with TrypLE and seeded onto
laminin-coated (11243217001, Roche, Palo Alto, CA) coverslips in
12-well plates (07-200-82, Fisher) at a density of 40,000 cells/cm
2.
On day 24, cells were fixed for 15 minutes in 4% paraformalde-
hyde (PFA) (15714-S, Electron Microscopy Sciences, Hatfield, PA)
for immunocytochemistry (ICC). On the day of plating for ICC,
cells were exposed to TrpLE for 3 minutes, suspended at lower
concentration in HBSS (Invitrogen), gently triturated with a 25 ml
pipet 7 times and centrifuged at 250 g for three minutes. The
resulting pellet was resuspended in HBSS once more and samples
were taken for cell counts. Cells were counted on a hemocytometer
until at least 100 cells of each sample were counted.
RPE Differentiation
RPE differentiation was conducted using 2 distinct protocols,
both of which did not require a sphere-forming stage. The first
protocol was used to illustrate the principle that phESC were
capable of end-product differentiation using protocols that lack a
sphere-forming stage. The second protocol was used to confirm
this finding.
In the first method, RPE differentiation as described by
Klimanskaya et al. [10] was carried out on four lines: H9,
LLC2P, LLC6P and LLC8P. Briefly, undifferentiated hESC and
phESC, adherent on a feeder layer of human neonatal skin
fibroblasts, were allowed to overgrow (about 7–10 days after
passaging) until the colonies lost their tight borders and became
multilayered, at which time bFGF was withdrawn from culture
medium, inducing spontaneous differentiation. Conditions were
maintained for 4–8 weeks during which time the medium was
changed every 1–2 days. To isolate colonies of RPE- like cells,
adherent cultures of spontaneously differentiated hESC and
phESC cells were rinsed with PBS twice and incubated in
collagenase IV at 37uC until the monolayer loosened. Cells from
pigmented regions were scraped off with a glass capillary, washed
in fresh culture medium and plated onto gelatin-coated plates in
RPE medium (high glucose KODMEM supplemented with
500 mg/mL of penicillin, 500 mg/mL of streptomycin, 1% non-
essential amino acids, 2 mM of GlutaMAX-I, 0.1 mM_b-
mercaptoethanol, 7% SR, and 5% fetal bovine serum (all
Invitrogen)). The medium was changed after the cells attached
(usually in 1–2 days) and every 5–7 days after that; the cells were
passaged every 2–4 weeks with 0.05% Trypsin/0.53 mM of
EDTA (Invitrogen).
In the second method, a novel protocol was followed.
Undifferentiated hESC and phESC growing in matrigel-adherent
culture were brought to confluence prior to differentiation. On
days 1 and 2 of differentiation, cells were fed serum replacement
(SR) medium supplemented with 10 ng/ml bFGF. After dissoci-
ation, cells were incubated for 3 days in SR medium supplemented
with 10 ng/ml bFGF and 10 mM RA. SR medium consisted of
DMEM/F12 with 15% knockout serum replacement (Invitrogen).
For the duration of the protocol, cells were fed RPE medium
supplemented with 5 ng/ml bFGF and 10 mM RA. RPE medium
consisted of DMEM/F12 with B27 supplement (Invitrogen) and
Insulin/Transferrin/Selenium supplement (Invitrogen) as per
manufacturer’s recommendation. On day 20, cells were plated
onto a Matrigel-coated adherent substrate. On day 42 of the
differentiation protocol, pigmented clusters of cells were mechan-
ically isolated and plated in uncoated flasks in RPE medium.
Immunocytochemistry
In some cultures of undifferentiated hESC and phESC the
mitotic index was determined using BrDU incorporation assays
and Ki67 immunostaining. Undifferentiated phESC were plated
in 4-well chamber slides 3 days before hESC were plated to ensure
that both populations would reach 60% confluence on the same
day. At the point of 60% confluence, media in BrdU wells was
supplemented with 10 mM BrdU (Sigma-Aldrich). Twenty-four
hours later, chambers were rinsed three times with warm HBSS
and fixed in 4% paraformaldehyde (Electron Microscopy Sciences)
for 15 minutes. Immunocytochemistry was carried out as
described in the following paragraph regarding NPC cultures
except the primary antisera used (mouse anti-BrdU, 1:250,
Millipore; rabbit anti-Ki67, 1:1000, Abcam).
NPC cultures were washed in PBS and fixed in 4%
paraformaldehyde (Electron Microscopy Sciences) for 15 minutes,
then washed three times in PBS. Immunocytochemical staining
was performed using standard protocols. Slides were blocked for
30 minutes at room temperature in 5% normal goat serum (NGS)
(Invitrogen). Primary antisera (mouse anti-Nestin, 1:200, Chemi-
con, Temecula, CA; rabbit anti-Pax 6, 1:500, Chemicon; mouse
anti-Map2, 1:500, Chemicon; rabbit anti-Olig1, 1:200, Chemicon;
mouse anti-SSEA, 3/4 1:200, Chemicon; rabbit anti-GFAP,
1:1000, Chemicon) were diluted in 5% NGS and incubated
overnight at 4uC. Slides were washed three times in PBS and
incubated one hour at room temperature in AlexaFluor conju-
gated antisera (goat anti-mouse IgG (H+L) AlexaFluor 488,
A11029, goat anti-rabbit IgG (H+L) AlexaFluor 488, A11034,
Invitrogen). Slides were washed 3 times in ddH2O and incubated
for 5 minutes at room temperature in 3.2 mM Hoechst (H3569,
Invitrogen). Slides were washed 3 times in ddH2O and cover-
slipped using Fluoromount G (0100-01, Birmingham, AL). Images
were captured using a Nikon Eclipse Ti microscope with 10X and
20X objectives and a Nikon Digital Sight DS-Fi1 camera.
RPE cultures were washed in PBS and fixed in 4%
paraformaldehyde at room temperature for 15 minutes. Following
permeabilization with 0.1% Triton-X100/PBS for 40 min, the
cells were rinsed with PBS and incubated overnight at 4uCi na
humidified chamber with the primary antibody: ZO1 (1:50,
Invitrogen), RPE-65 (1:250, Novus Biologicals), Bestrophin (1:25,
Novus Biologicals), Occludin (1:50, Santa Cruz Biotechnology,
Inc.) and CRALBP (1:50, Santa Cruz Biotechnology, Inc.). The
cells were rinsed three times with PBS for 15 min and incubated at
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Fluor 546 donkey anti-mouse, Alexa Fluor 488 donkey anti-
mouse, Alexa Fluor 546 donkey anti-rabbit or Alexa Fluor 488
donkey anti-goat (1:1000, Invitrogen). The cells were then washed
five to six times in PBS, covered with mounting medium with
DAPI (Vector Laboratories, Inc.) and examined with the
microscope (Zeiss Axio Imager).
Western Analysis
The cells were lysed on ice in chilled RIPA lysis buffer
(Millipore) and supplemented with protease inhibitor cocktails
(Roche Applied Science). The cell extracts were centrifuged at
14,000 g for 15 minutes at 4uC. Supernatants were collected after
centrifugation. Protein content was quantified using the Bradford
assay (Sigma-Aldrich) according to the manufacturer’s guidelines.
The protein samples (50 mg per lane) were electrophoretically
separated by SDS-PAGE in 4–20% gradient gel (PAGEgel, Inc.).
After electrophoresis, proteins were transferred to a Hybond-P
polyvinylidene difluoride (PVDF) membrane (GE Healthcare
Biosciences). Membranes were blocked for 2 hours in 5% nonfat
milk in PBS-0.05% Tween-20 and incubated 2 hours in 5%
nonfat milk containing primary antibodies: RPE-65 (1:5000,
Novus Biologicals), Bestrophin (1:1000, Novus Biologicals) or
NCAM1 (1:2000, Santa Cruz Biotechnology, Inc.). Membranes
were washed in PBS-0.05% Tween-20, then incubated for 1 hour
at room temperature with secondary HRP-conjugated antibody
goat anti-mouse (1:1000, Millipore). After the membranes were
washed, the proteins were visualized using Enhanced Chemilu-
minescence Plus Western blotting detection system (GE Health-
care Biosciences) according to the manufacturer’s protocol.
Protein bands were detected by exposure to autoradiographic
film (Amersham Hyperfilm ECL, GE Healthcare Biosciences).
RPE Phagocytosis
RPE cultures generated from the LLC6P line were processed
with the pH-rhodo BioParticles Conjugates for Phagocytosis kit
(Invitrogen). Lyophylized pHrodo BioParticles fluorescent particles
were dissolved in RPE medium at a concentration of 1 mg/mL
according to manufacturer’s recommendations. Adherent cultures
in 6-well plates were fed with medium containing fluorescent
particles. Beginning 5 minutes after addition of fluorescent
particles, plates were imaged every 15 minutes for 2.5 hours with
a Leica LSM 510 using 550 nm excitation and a 10x objective.
Cells were fixed with 4% paraformaldehyde after the assay.
Small sheets were taken off the dish, placed on a slide, coverslipped
with DAPI (4969-diamidino-2-phenylinode hydrochloride) con-
taining Vectashield mounting medium (Vector Labs), and imaged
on a Leica LSM710 confocal microscope, using a 63x objective to
verify that the particles were inside the cells.
Results
Undifferentiated Cell Culture
In the undifferentiated state, phESC exhibited different growth
characteristics than hESC. Grown in feeder-free conditions, hESC
colonies were observed within 1 day of passaging and cultures
reached confluence within 7 days. In the same conditions, phESC
colonies were observed within 1 day and reached confluence in
10–12 days. Statistically fewer (p,0.01) phESC colonies (38
colonies +-8) adhered after passaging when cells were split at the
same plating density (50,000 cells/cm
2) as conventionally-derived
hESC (202 colonies +-36). Once plated, colonies exhibited altered
morphology (Fig. 1). The phESC colony-stroma border was
irregular and not clearly defined. The hESC colonies were more
round in shape and clearly delineated from surrounding stroma.
Stroma, the long, thin cells between stem cell colonies, were not as
prevalent in phESC cultures.
The rate of proliferation differed between hESC and phESC.
BrdU incorporation assays indicated that the average number of
BrdU positive cells was statistically greater (p,0.01) in hESC
cultures (11.23%61.44%) than phESC cultures (4.57%6
1.07%). Ki67 staining indicated that the average number of
Ki67 positive cells was not significantly different (p,0.01)
between hESC cultures (97.92%60.41%) and phESC cultures
(98.45%60.45%).
Gene expression as determined by pluripotency-specific PCR
array showed no differences between undifferentiated samples of
hESC and phESC (Fig. 2a). Methylation microarray (GEO Series
accession number GSE25538) revealed that epigenetically, phESC
and hESC were more similar to each other than they were to cell
line and tissue samples, but they were not indistinguishable
(Fig. 2b). Differences in the number of CpG sites with different
methylation patterns were most pronounced when filtered to
include only imprinted loci (Fig. 2c, d). Methylation data
(unmethylated + methylated)/(unmethylated + methylated +
partially methylated) were normalized with tissue lines as the
unmethylated baseline. Requiring partially methylated sites to be
consistent across all five tissue samples yielded identification of 92
CgG sites representing 23 of 47 imprinted genes. When one tissue
sample was allowed discordance (4/5 agreed), 30 of the 47 were
identified. As expected of cells of uniparental origin, 49% (45 of
92) of CpG sites were either methylated or unmethylated and
100% of these sites were consistent with maternal imprinting.
Probes identified as imprinted by partial methylation status in
tissue samples were consistently partially methylated in the cell line
samples as well. Of the 47 imprinted genes in beadstudio, 45 were
differentially methylated between the phESC samples and hESC
samples.
NPC Differentiation
On the last day of the standard differentiation protocol (Day
21), cells were plated at lower density for terminal differentiation.
hESC-derived NPC cultures (Fig. 3a, b) were dense whereas
phESC-derived cultures (Fig. 3c, d) were not. At no point do cells
in this protocol form rosettes. Three successive differentiations of
each line were quantified (Fig. 3e), each grow beginning as 75 cm
2
original surface area of subconfluent hESC. The CSC14 line
yielded 28.25 (61.20), 20.06 (60.45) and 16.03 (60.41) million
cells for a mean of 21.45 (62.935) million. The H7 line yielded
21.00 (60.44), 23.25 (60.73) and 17.62 (61.47) million cells for a
mean of 20.62 (61.336) million. The LLC6P line yielded 0.73
(60.03), 3.34 (60.07) and 7.06 (60.03) million cells for a mean of
3.71 (61.501) million. The LLC8P line yielded 2.65 (60.04), 3.65
(60.02) and 4.46 (60.05) million cells for a mean of 3.59 (60.427)
million cells.
NPC were characterized on day 24 of culture (Fig. 4). Many
NPC derivates of hESC origin labeled positive for Nestin, Pax6
and Map2 and virtually all labeled positive for Olig1, indicating a
neuronal phenotype. NPC derivates of phESC origin did not label
with Map2 and Olig1, but many labeled immunopositive for
Nestin and Pax6, indicating a relatively immature neuronal
phenotype. No SSEA 3/4-positive cells from the hESC groups
could be detected, indicating that these cultures did not contain
any undifferentiated stem cells. Occasional clusters of SSEA 3/4-
positive cells were observed in the phESC group, indicating that
these cells persisted in the undifferentiated state despite lineage
direction provided by the differentiation protocol. Occasional
single GFAP positive cells were observed in derivates of all four cell
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showed no immunoreactivity in no-primary-antibody immunocy-
tochemical control staining chambers.
During the phase of the NPC protocol where cells are plated in
ultra-low adherence 6-well plates, the phESC required particularly
gentle feeding techniques as the spheres required to achieve
Figure 2. Undifferentiated colonies differed with respect to imprinted genes. PCR arrays did not reveal differences in the undifferentiated
state (a). Parthenote-derived lines LLC6P and LLC8P are plotted on the y-axis and conventionally-derived lines H7 and CSC14 on the x-axis.
Methylation microarray revealed differences between parthenote-derived lines and conventionally-derived lines, most notably in imprinted genes.
Cluster analysis (b) indicated that phESC and hESC were closely related to each other and more methylated than tissue and primary cell lines. phESC
and hESC are distinguishable when complete methylation data are included (c). phESC and hESC diverge further when methylation data include only
imprinted genes (d). Methylation data, normalized with tissue lines as the unmethylated baseline (c and d). In c and d, correlation is plotted on the y-
axis and level of discordance between 7 phESC lines is plotted on the x axis (e.g. 4 means 3 phESC lines were allowed discordance). Red represents
phESC lines, green represents hESC lines, blue represents primary cell lines and dashed purple represents tissue lines.
doi:10.1371/journal.pone.0014499.g002
Figure 1. hESC and phESC differ morphologically. Conventionally-derived (a–f) and parthenote-derived (g–l) hESCs have distinct morphology
and growth patterns in the undifferentiated state. High magnification and low magnification images have been provided for each colony to illustrate
the slower growth of parthenote-derived colonies, irregular colony shape and lack of stromal cells (long, thin cells between colonies indicated by
arrows) in the phESC cultures. Day 1 after plating (a, d, g and j). Day 2 after plating (b, e, h and k). Day 4 after plating (c, f, i and l). Scale bars represent
20 mm (a–c and g–i) and 10 mm (d–f and j–l).
doi:10.1371/journal.pone.0014499.g001
Equivalence of hESC and phESC
PLoS ONE | www.plosone.org 5 January 2011 | Volume 6 | Issue 1 | e14499appropriate cell-cell signaling were more prone to dissociation
than those of their hESC counterparts (Fig. 5a, 5b).
Extracellular matrix expression as determined by ECM PCR
array showed differences (Fig. 5c). Compared to hESC, phESC
showed -422.77 fold-regulation of MMP7, -208.23 fold-regulation
of MMP1, -102.8 fold-regulation of VCAM1 and -26.42 fold-
regulation of NCAM1. Other differences are summarized in
Fig. 5d. Western blot analysis confirmed differential expression of
NCAM1 (Fig. 5e). The 180K isoform of NCAM1 commonly
found in the central nervous system was clearly detected in hESC-
derived NPC samples. Neither the 180K nor the 140K isoforms
were detected in great amounts in phESC-derived NPC sample.
RPE Differentiation
When phESC and hESC cultures were allowed to spontane-
ously differentiate, both cell types lost their typical undifferentiated
morphology and formed three-dimensional multicellular struc-
tures. Pigmented colonies of epithelial-like cells surrounded by cells
of other phenotypes became visible approximately 4–6 weeks after
bFGF withdrawal from culture medium; 8 weeks later a significant
number of pigmented colonies were visible as ‘‘freckles’’ in the
culture dishes of both tested cell types. Pigmented cells were
handpicked and plated onto gelatin coated dishes for outgrowth.
The cells lost pigmentation and epithelial morphology as they
divided and migrated away from the initial attachment site,
however, once confluence was established, the cells reverted to
epithelial morphology and re-expressed pigment (Fig. 6a) as has
been previously described for RPE [11,12,13] and for hESC-
derived RPE [10]. These established monolayers of RPE-like cells
were routinely passaged every 2–4 weeks and have undergone six
passages to date. Cultures derived from both hESC and phESC
demonstrated typical characteristics of RPE. During cultivation of
established RPE monolayers ‘‘dome’’-like structures were observed
(Fig. 6b). The presence of these structures indicates proper
polarization, formation of tight junctions and transport of ions to
the basal side [14,15].
The immunolocalization of RPE-specific markers demonstrated
that both phESC- and hESC- derived RPE express Occludin
(Fig. 6c), CRALBP, mitf (Fig. 6d), RPE65, Bestrophin, and tight
junction marker ZO-1. The expression of RPE65 and Bestrophin
were confirmed by western blot analysis (data not shown).
Exposure of differentiated cells to pHrhodo BioParticles
demonstrated RPEs derived from phESC are capable of
phagocytosis. Five minutes after application of the fluorescent
particles, cells contained relatively little vesicular pHrhodo
(Fig. 6e). Two hours later, vesicular pHrhodo content markedly
increased (Fig. 6f). Confocal imaging after fixation confirmed that
the fluorescent particles were contained within the cells (data not
shown).
The findings outlined above were consistent using two distinct
differentiation protocols, both of which lacked a sphere-forming
stage. The first protocol was used to illustrate the principle that
phESC were capable of end-product differentiation using
protocols that lack a sphere-forming stage. The second protocol
was used to confirm this finding.
Discussion
Human embryonic stem cells can give rise to all cell types in the
body and are a valuable tool to make differentiated cells for drug
screening, predictive toxicology and potentially therapeutic
applications. Therapeutic use of stem cell derived cell populations
would be augmented if they did not induce an immune response in
the host that would result in rejection of cells. Although
preliminary data suggest that cell transplant populations differen-
tiated from hESCs in vitro do not express an immunogenic HLA
profile [16], the long-term immune effects are unknown. It is most
likely that an autologous or immune-matched transplant would be
best tolerated by the recipient. phESCs are pluripotent stem cells
that can be made HLA homozygous for simplified immune
matching, but their differentiation potential and biases are
understudied. A greater understanding of the differentiation
potential and differentiation bias of multiple cell types is needed
Figure 3. Exposure of hESC and phESC to a neural differenti-
ation protocol yields quantitatively distinct cell populations.
Conventionally-derived (a and b) and parthenote-derived (c and d)
hESC have distinct growth patterns after the NPC differentiation
protocol. Histograms plotting cellular yield (in millions of cells) after
NPC differentiation (e) reveal that parthenote-derived lines yield fewer
cells after differentiation than conventionally-derived lines. Scale bars
represent 10 mm. Blue bars indicate differentiation 1, red bars indicate
differentiation 2 and yellow bars indicate differentiation 3, representing
the three successive differentiations.
doi:10.1371/journal.pone.0014499.g003
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research or clinical need at hand. In this study we identify points of
equivalence and non-equivalence between hESC and phESC.
Our data indicate that the in vitro directed NPC differentiation
protocol resulted in poor yield from phESC compared to hESC,
most likely due to a difference in cell-cell interaction resulting from
differences in ECM expression. We corrected for the possibility
that decreased proliferation in the undifferentiated state led to an
apparent difference in final yield by maintaining undifferentiated
cultures as long as was necessary to reach comparable confluence.
The NPC protocol included a culture step consisting of neuro-
sphere formation, which relied heavily on cell-cell interaction. Our
PCR data revealed that phESCs and hESCs had a different
expression pattern of extracellular matrix proteins, suggesting that
while the neurosphere step may be ideal for the hESC cultures, it
may be detrimental to the phESC cultures. Indeed, we observed a
lack of adherence between phESC derivates, resulting in poor
sphere forming capability, and poor adherence to surfaces. At day
6 through day 14 of the differentiation protocol, hESCs typically
formed round, relatively stable spheres that held together during
feeding of cells in suspension. phESCs had a tendency to dissociate
and form smaller spheres or dissociate to the single-cell level. Since
this feeding selects for the larger, uniform hESC-type spheres, it is
not surprising that a problem at this stage would lead to
dramatically decreased yield.
The possibility that phESCs cannot efficiently produce cells of
the neural lineage is ruled out by the successful generation of RPE,
which are of the neural lineage. The RPE yield and purity was
equivalent in the phESC and hESC cultures. Notably, the RPE
differentiation protocols did not rely on a sphere-formation step
during culture, suggesting that the apparent inequality in
differentiation potential demonstrated in the NPC differentiation
study may have resulted from differences in ECM proteins and
was thus an artifact of the protocol.
Our PCR data support the idea that the altered ECM profile of
phESC derivates may contribute to their poor spherogenic nature.
Multiple adhesion molecules and their regulators are expressed at
different levels between hESC and phESC derivates. Relevant to
successful generation of RPE from phESC, Col7A1, a collagen
present in several layers of the retina [17], was elevated in phESC
derivates. hESC derivates express elevated levels of four MMPs,
indicating expression of these MMPs does not preclude sphere
formation at this stage, possibly because co-expression of their
regulators or targets ameliorate their anti-adhesive effects. For
example, MMP13 (elevated in hESC derivates) preferentially
cleaves type II collagen [18], which is also elevated in hESC as
Col11A1. In addition, hESC derivates express elevated TIMP2,
an inhibitor of MMPs [19]. hESC derivates express 26.42 fold
higher levels of NCAM1 than their phESC counterparts.
Decreased NCAM1 expression may contribute to loss of cells,
Figure 4. Immunocytochemical profile following NPC differentiation. Parthenote-derived lines displayed impaired neural maturation, but
expressed immature markers normally. CSC14 (a–d), H7 (e–h), LLC6P (i–l) and LLC8P (m–p). Map2 (a, e, i and m), Olig1 (b, f, j and n), Nestin (c, g, k and
o) and Pax6 (d, h, l and p). Scale bars represent 50 mm (a, b, e and f) and 10 mm (c, d, and g–p).
doi:10.1371/journal.pone.0014499.g004
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consumed media, and by loss of trophic support. NCAM1
activates the FGF receptor when clustered NCAM1 is involved
in trans-homophilic binding [20]. FGF provides not only
differentiation cues, but also trophic support [21], without which
the phESC in our NPC protocol may have been at an additional
disadvantage.
For therapeutic use, there are a number of practical
considerations when choosing the appropriate cell type. Should
Figure 6. phESC produce functional RPE cells after differenti-
ation. The LLC6P line produces pigmented cells in culture (a) and
characteristic ‘‘dome-like’’ structures (b). Cells express RPE markers
Occludin (c), CRALBP and mitf (d). Functionality of LLC6P-derived RPE is
demonstrated by pHrhodo pH-sensitive fluorescent particle phagocy-
tosis (e and d). Five minutes after administration of pHrhodo (e), RPE
exhibit minimal vesicular pHrhodo content. Two hours and five minutes
after administration (f), RPE exhibit marked increase in vesicular
pHrhodo content. Scale bars represent 100 mm (a, e, f), 500 mm (b)
and 5 mm (c, d).
doi:10.1371/journal.pone.0014499.g006
Figure 5. phESC display altered ECM profile and do not readily
form spheres in non-adherent culture. During the sphere-forming
stage of the NPC protocol, hESC gave rise to clusters that readily formed
spheres with minimal dissociation (a). phESC at the same stage
consistently dissociated (b). PCR arrays revealed differences in
extracellular matrix and adhesion molecules in NPC (c). Parthenote-
derived lines LLC6P and LLC8P are plotted on the y-axis and
conventionally-derived lines H7 and CSC14 on the x-axis. Details of
differentially expressed genes are presented numerically (d). Western
blot analysis confirmed differential expression of NCAM1 (e). Scale bars
represent 20 mm (a–b).
doi:10.1371/journal.pone.0014499.g005
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tremendous advantages for immune tolerance. Similar advantages
could be realized with hESCs and iPS, however; there are
drawbacks to using these two cell types that can be avoided with
phESCs. hESCs express no human leukocyte antigen (HLA)-DR,
DP, DQ and only low levels of HLA-A, B, C even when exposed
to pro-inflammatory cytokines [16,22,23], but it is not yet clear
how differentiated cells would be tolerated long-term. iPS
technology suffers from increased tumorigenesis, low efficiency,
and the time it takes to generate an immune-matched line would
render it inadequate for acute needs. An additional commercial
strength of phESCs is that their increased immune tolerance may
broaden the range of patients who stand to benefit from each line.
With rising health care costs, efficient production may be essential
to opening the possibility of therapy to the greatest number of
patients. A system in which a new line must be created for each
patient may not be economically feasible, and will be technically
inferior. phESCs can be immune matched for simplified long-term
tolerance and can be banked and stored for efficient production
and timely availability. When choosing a line for commercial scale
up, cellular yield is an important measure to consider. The cost of
expansion and differentiation can be immense, so addition of
financial and temporal burdens caused by decreased yield is not
desirable. These findings and needs underscore the importance of
determining comparative differentiation biases and differentiation
potential.
In conclusion, our data indicate that stem cell differentiation
protocols are specific to stem cell types, and that phESCs have a
unique ECM and methylation profile which renders differentiation
protocols containing a spherogenic step unsuitable for this stem
cell population. Thus, inappropriate differentiation protocols mask
differentiation potential.
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